CHINA HAS ESTABLISHED BIO CHEMICAL WARFARE LABS IN PAKISTAN TO PREVENT CORONA TYPE VIRUS LEAK IN MAINLAND CHINA

- Pakistan and China have entered a secret three-year deal to expand potential bio-warfare capabilities, including running several research projects related to the deadly agent anthrax.

- Wuhan Institute of Virology has signed the covert deal with Pakistan military’s Defense Science and Technology Organization (DESTO), to collaborate research in “emerging infectious diseases” and advance studies on the biological control of transmitted diseases.

- Program is being entirely funded by China and is formally titled the “Collaboration for Emerging Infectious Diseases and Studies on Biological Control of Vector Transmitting Diseases”.

- China is testing biological agents outside its borders (in Pakistan) in an apparent bid to minimize the “risk of drawing condemnation from the international community”.

- DESTO has been engaged in various dual-use research projects related to anthrax under a covert biological weapons program.

- The covert China-Pakistan project has conducted “successful soil sampling tests” to isolate Bacillus Thuringiensis (BT), which has a “striking similarity” to Bacillus Anthracis – or anthrax.

- The Wuhan lab was providing “extensive training on manipulation of pathogens and bio-informatics” to Pakistani scientists “to help Pakistan develop its own virus collection database”.  

- The secret project was “detached from supervision of civilian universities or government health departments in Pakistan” and was structured so as to allow “unspecified” future operations.

- China’s keen interest in the project is driven chiefly by its agenda to engage Pakistan against India and to conduct potentially dangerous experiments on foreign soil, without subjecting its own land and people to risk

- The plan was part of a move by Beijing to “designate Pakistan a destination for hazardous bio chemical research” while “evading use of its own territory for such activities”, which “stand the risk of drawing criticism and condemnation from the international community”

- The China-Pakistan biological project had already undertaken experiments on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV). CCHFV is a rapid-onset fever virus that causes death in about 25% of cases and is similar to the Ebola virus.CCHFV is categorised as a “class-4” microorganism – the highest possible risk category.

- Pakistan is allegedly carrying out tests on CCHFV in laboratories which are not equipped to handle Bio-Safety Level-4 diseases. 

- There were concerns the Kunming facility, which is controlled by the Chinese Academy of Medical Sciences, was also handling class-4 diseases without proper protections